Evidence map›Paper›PMID 41495414›Full record

Trial reportScientific reports2026

Effects of diacylglycerol-enriched alpha-linolenic acid oil on skin properties in mild skin discomfort: a randomized, double-blind, placebo-controlled study.

Satoko Fukagawa, Yoshie Shimotoyodome, Keimon Sayama, Aya Sasaki, Katsuyoshi Saito, Hiroki Fujita, Yuki Shimizu, Koichi Misawa, Shinichiro Saito, Junko Ishikawa and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Satoko FukagawaHuman Health Care Products Research, Kao Corporation, Bunka 2-1-3, Sumida, Tokyo, 131-8501, Japan. fukagawa.satoko@kao.com.
Yoshie ShimotoyodomeHuman Health Care Products Research, Kao Corporation, Bunka 2-1-3, Sumida, Tokyo, 131-8501, Japan.
Keimon SayamaDepartment of Biochemistry, Juntendo University Graduate School of Medicine, Hongo 2-1-1, Bunkyo, Tokyo, 113-8421, Japan.
Aya SasakiHuman Health Care Products Research, Kao Corporation, Bunka 2-1-3, Sumida, Tokyo, 131-8501, Japan.
Katsuyoshi SaitoHuman Health Care Products Research, Kao Corporation, Bunka 2-1-3, Sumida, Tokyo, 131-8501, Japan.
Hiroki FujitaBiological Science Research, Kao Corporation, Akabane 2606, Ichikai-Machi, Haga-Gun, Tochigi, 321-3497, Japan.
Yuki ShimizuHuman Health Care Products Research, Kao Corporation, Bunka 2-1-3, Sumida, Tokyo, 131-8501, Japan.
Koichi MisawaHuman Health Care Products Research, Kao Corporation, Bunka 2-1-3, Sumida, Tokyo, 131-8501, Japan.
Shinichiro SaitoHuman Health Care Products Research, Kao Corporation, Bunka 2-1-3, Sumida, Tokyo, 131-8501, Japan.
Junko IshikawaDepartment of Biochemistry, Juntendo University Graduate School of Medicine, Hongo 2-1-1, Bunkyo, Tokyo, 113-8421, Japan.
Noriyasu OtaBiological Science Research, Kao Corporation, Akabane 2606, Ichikai-Machi, Haga-Gun, Tochigi, 321-3497, Japan.
Takehiko YokomizoDepartment of Biochemistry, Juntendo University Graduate School of Medicine, Hongo 2-1-1, Bunkyo, Tokyo, 113-8421, Japan.
Masanobu HibiHuman Health Care Products Research, Kao Corporation, Bunka 2-1-3, Sumida, Tokyo, 131-8501, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin barrier function impairment and inflammation promote allergen invasion through the skin, leading to sensitization and exacerbation of allergic diseases. Intake of linseed oil, an oil rich in alpha-linolenic acid (ALA), suppresses inflammation and allergic symptoms. To our knowledge, the effects of diacylglycerol-enriched ALA (ALA-DAG) oil intake on skin properties and allergic symptoms have not been evaluated. We performed a double-blind, randomized, placebo-controlled, parallel-group study of 60 individuals aged 20-59 years with mild skin discomfort, including dryness, itching, and redness, to investigate the effects of ALA-DAG intake on skin and allergic symptoms. Participants were divided into two groups treated with either 2.5 g/day of ALA-DAG or placebo oil for 8 weeks. The skin properties were measured at baseline and at 8 weeks. Allergic symptoms were measured at 4 and 8 weeks. Compared with placebo oil intake, ALA-DAG intake increased skin hydration in the cheek, reduced nasal congestion and nose itchiness, and decreased mite-specific immunoglobulin E in the blood. Subgroup analysis showed that participants who were positive for mite allergen sensitization had reduced facial redness after ingesting ALA-DAG. These findings suggest that ALA-DAG intake improves skin properties and alleviates allergic symptoms.

Indexed as

alpha-Linolenic AcidDiglyceridesLinseed OilSkinAdultDouble-Blind MethodFemaleHumansImmunoglobulin EMaleMiddle AgedYoung Adultalpha-Linolenic AcidDiglyceridesImmunoglobulin ELinseed OilAlpha-linolenic acidDiacylglycerol-enriched alpha-linolenic acid oilIgEOmega-3 polyunsaturated fatty acidsSkin surface lipid RNA

Identifiers

PMID41495414
PMCPMC12873180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.